We look forward to new techniques and refinements in existing techniques to further reduce the already low complication rate associated with cosmetic oculoplastic surgery. Advances in laser delivery systems continue to evolve, and may further improve the appearance of skin with our surgical results that continue to be a limiting factor. Current interest in wound healing via stem-cell research may solve some of the current issues with postoperative scarring. Future developments will also focus on prevention through the use of antiaging therapies to slow or reverse solar damage, maintain and improve skin elasticity, and other methods that reduce the myriad of components of facial aging. There is also the potential for many of the newer injectable agents for selective chemodenervation and soft tissue augmentation that will be longer lasting, and will use components that prevent not only the normal biologic biodegradation of the implant, but the native soft tissue as well.
The knowledge of our history in this field, a better understanding of the periorbital aging process, and improved techniques, products, and devices will ultimately improve the resources of surgeons for better and longer lasting patient outcomes.
No comments:
Post a Comment